Discoidin domain receptor 1, a melanoma immunomodulator

Discoidin domain receptor 1, a melanoma immunomodulator

Saved in:

Bibliographic Details
Main Authors:	C. Lutz, A. Lourenço, C. Reger de Moura, B. Louveau, A. Marie-Cardine, C. Lebbé, S. Mourah
Format:	Article
Language:	English
Published:	Elsevier 2024-01-01
Series:	EJC Skin Cancer
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772611824001095
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Kindlin-3 inactivation mediates melanoma agressiveness through crosstalk with the collagen-activated tyrosine kinase receptor DDR1
by: C. Reger de Moura, et al.
Published: (2024-01-01)

Discoidin domain receptors; an ancient family of collagen receptors has major roles in bone development, regeneration and metabolism
by: Renny T. Franceschi, et al.
Published: (2023-05-01)

Discoidin domain receptor 2 is an important modulator of BMP signaling during heterotopic bone formation
by: Fashuai Wu, et al.
Published: (2025-01-01)

Whole transcriptome sequencing: Optimizing molecular classification and management of rare skin cancers
by: B. Louveau, et al.
Published: (2024-01-01)

Histone Arginine Methylation-Mediated Epigenetic Regulation of Discoidin Domain Receptor 2 Controls the Senescence of Human Bone Marrow Mesenchymal Stem Cells
by: Zhenyu Xu, et al.
Published: (2019-01-01)

Immunomodulation by Gut Microbiota: Role of Toll-Like Receptor Expressed by T Cells
by: Mariagrazia Valentini, et al.
Published: (2014-01-01)

Timosin alpha-1 immunomodulating properties
by: M. V. Mayevskaya
Published: (2009-02-01)

Identifying Promising Immunomodulators for Type 1 Diabetes (T1D) and Islet Transplantation
by: Nida Ajmal, et al.
Published: (2024-01-01)

Efficacy of neoadjuvant pembrolizumab in a primary cutaneous stage II non-operated melanoma
by: M. Amiot, et al.
Published: (2024-12-01)

Erratum to ‘Molecular profiling of anal Paget’s disease and underlying anal adenocarcinoma highlights their common origin’ [EJC Skin Cancer 1 (2023) 100002]
by: Yaëlle Bellahsen-Harrar, et al.
Published: (2024-12-01)

Comparison of Concomitant Mesalamine and Immunomodulator Therapy and Immunomodulator Monotherapy for Crohn’s Disease
by: Min Seob Kwak, et al.
Published: (2018-01-01)

Clinical and Experimental Immunomodulation 2014
by: Lenin Pavón, et al.
Published: (2015-01-01)

Clinical and Experimental Immunomodulation 2016
by: Lenin Pavón, et al.
Published: (2017-01-01)

Clinical and Experimental Immunomodulation
by: Lenin Pavón, et al.
Published: (2013-01-01)

Molecular Imaging and Radionuclide Therapy of Melanoma Targeting the Melanocortin 1 Receptor
by: Chengcheng Zhang PhD, et al.
Published: (2017-11-01)

Role of the androgen receptor in melanoma aggressiveness
by: Marzia Di Donato, et al.
Published: (2025-01-01)

Immunomodulation by allograft endothelial cells
by: Sayantan Bose, et al.
Published: (2025-02-01)

Molecular profiling of anal Paget’s disease and underlying anal adenocarcinoma highlights their common origin
by: Yaëlle Bellahsen-Harrar, et al.
Published: (2023-01-01)

First evidence of immunomodulation of the renin-angiotensin system through substance P/neurokinin 1 receptor: a case and control study in hypertension and cardiac patients
by: Ibrahim M. Alanazi, et al.
Published: (2025-02-01)

Sinonasal Melanoma: A Case Report and Literature Review
by: I. S. S. Alves, et al.
Published: (2017-01-01)

Melanocortin 1 Receptor Targeted Imaging of Melanoma With Gold Nanocages and Positron Emission Tomography
by: Yongfeng Zhao PhD, et al.
Published: (2018-05-01)

Antiinflammatory and Immunomodulating Properties of Fungal Metabolites
by: Cristina Lull, et al.
Published: (2005-01-01)

Antigen-Induced Immunomodulation in the Pathogenesis of Atherosclerosis
by: Natalia Milioti, et al.
Published: (2008-01-01)

Immunomodulation Induced by Host Pathogen Interaction
by: Hadi M. Yassine, et al.
Published: (2019-01-01)

Effects of Canned Pineapple Consumption on Nutritional Status, Immunomodulation, and Physical Health of Selected School Children
by: Mavil May C. Cervo, et al.
Published: (2014-01-01)

Immunomodulation as the main characteristic of vegetable oils: a review
by: D.P. Tres, et al.
Published: (2024-09-01)

AMBRA1 is a predictive biomarker of melanoma response to targeted therapy
by: L. Di Leo, et al.
Published: (2024-01-01)

Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment
by: Eric A. Smith, et al.
Published: (2024-12-01)

Unresectable endocrine mucin-producing sweat gland carcinoma revealing an actionable somatic CHEK2 gene mutation
by: S. Tzoumpa, et al.
Published: (2024-01-01)

Recurrent bronchitis immunomodulation in children with vertebrobasilar arterial system syndrome
by: L. S. Ovcharenko, et al.
Published: (2020-12-01)

Potential Application of Tregitopes as Immunomodulating Agents in Multiple Sclerosis
by: Wassim Elyaman, et al.
Published: (2011-01-01)

Skin adnexal carcinomas DNA genomic profiling uncovers oncogenic pathways and potential therapeutic targets
by: B. Louveau, et al.
Published: (2024-01-01)

Heparan Sulfate Proteoglycan–Involving Immunomodulation by Cathelicidin Antimicrobial Peptides LL-37 and PR-39
by: Nicole C. Kaneider, et al.
Published: (2007-01-01)

Bibliometric analysis of metformin as an immunomodulator (2013–2024)
by: Tongyi Zhou, et al.
Published: (2025-01-01)

Immunomodulation in the Treatment of Refractory Catastrophic Antiphospholipid Syndrome
by: Karthik Nath, et al.
Published: (2018-01-01)

Challenges and limitations in using bacterial metabolites as immunomodulators
by: Chinnashanmugam Saravanan, et al.
Published: (2025-01-01)

Immunomodulation to enhance the efficacy of an HPV therapeutic vaccine
by: Jeffrey Schlom, et al.
Published: (2020-05-01)

Retraction: Endothelin-1 Inhibits Prolyl Hydroxylase Domain 2 to Activate Hypoxia-Inducible Factor-1α in Melanoma Cells.
by: PLOS ONE Editors
Published: (2024-01-01)

Adrenergic/Cholinergic Immunomodulation in the Rat Model—In Vivo Veritas?
by: I. Rinner, et al.
Published: (1998-01-01)

High-resolution crystal structure of human coronavirus HKU1 receptor binding domain bound to TMPRSS2 receptor
by: Wei Wang, et al.
Published: (2024-12-01)